SIGA

SIGA Technologies Inc.

Regulated industry Physical products Sells to businesses Government contractsTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.35
52-Week Range: $2.83 – $8.95
Market Cap: $242.85M
P/E (TTM): —
EPS (TTM): -0.04
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 1.47
PEG Ratio: 3.37
Return on Equity: -1.49%
Return on Assets: -3.39%
Gross Margin: 16.28%
Operating Margin: 33.91%
Profit Margin: -5.19%
Current Ratio: 21.72
Debt/Equity: 0.00
Total Debt: $439.40K
Free Cash Flow: $-23.99M
Revenue Growth: -49.50%
Earnings Growth: -65.30%
Enterprise Value: $125.71M

SIGA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$110.78M	$139.92M	$138.72M	$94.57M
Cost of Revenue	$10.43M	$17.83M	$31.29M	$29.70M
Gross Profit	$100.34M	$122.09M	$107.43M	$64.87M
Research & Development	$22.53M	$16.43M	$12.31M	$19.96M
Selling, General & Admin	$35.12M	$22.04M	$25.14M	$21.21M
Operating Expenses	$57.64M	$38.47M	$37.45M	$41.17M
Operating Income	$42.70M	$83.62M	$69.98M	$23.70M
EBITDA	$43.22M	$84.16M	$70.52M	$24.26M
Pretax Income	$44.13M	$87.78M	$76.07M	$30.38M
Income Tax	$10.23M	$19.71M	$16.86M	$7.10M
Net Income	$33.90M	$68.07M	$59.21M	$23.28M
Diluted EPS	0.46	0.95	0.82	0.32
Diluted Shares	73.55M	71.68M	71.91M	71.87M

SIGA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$98.79M	$150.15M	$155.40M	$154.97M
Receivables	$45.41M	$21.13M	$21.17M	$3.26M
Inventory	$39.27M	$64.22M	$49.56M	$49.05M
Current Assets	$185.79M	$238.99M	$231.04M	$212.86M
Total Assets	$195.04M	$254.35M	$244.34M	$219.47M
Current Liabilities	$21.52M	$54.12M	$25.33M	$17.99M
Total Debt	$528.17K	$564.01K	$546.82K	$595.17K
Total Liabilities	$24.88M	$57.49M	$28.53M	$20.65M
Retained Earnings	-$63.80M	-$38.94M	-$22.84M	-$43.07M
Shareholders' Equity	$170.16M	$196.86M	$215.80M	$198.82M
Working Capital	$164.27M	$184.87M	$205.71M	$194.86M

SIGA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$41.61M	$94.80M	$48.76M	$43.47M
Capital Expenditure	—	-$21.69K	-$42.45K	-$355.01K
Free Cash Flow	$41.61M	$94.78M	$48.72M	$43.12M
Depreciation & Amortisation	$517.64K	$538.29K	$538.42K	$562.61K
Stock-Based Compensation	$1.78M	$2.05M	$3.64M	$3.68M
Investing Cash Flow	$0.00	-$21.69K	-$42.45K	-$355.01K
Financing Cash Flow	-$45.96M	-$43.42M	-$43.46M	-$43.55M
Dividends Paid	-$32.94M	-$32.14M	-$42.67M	-$43.12M
Share Repurchases	-$13.01M	-$11.07M	$0.00	$0.00
Net Change in Cash	-$4.35M	$51.36M	$5.25M	-$433.85K

SIGA Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$7.04M	$81.12M	$2.62M	$3.79M	$6.24M	$41.00M
Cost of Revenue	$157.74K	$25.55M	$1.00M	$2.99M	$2.94M	$17.56M
Gross Profit	$6.88M	$55.57M	$1.62M	$804.47K	$3.30M	$23.44M
Research & Development	$3.46M	$4.40M	$7.05M	$5.04M	$3.95M	$4.39M
Selling, General & Admin	$5.68M	$5.49M	$4.79M	$5.26M	$4.67M	$5.15M
Operating Expenses	$9.14M	$9.89M	$11.84M	$10.30M	$8.62M	$9.54M
Operating Income	-$2.26M	$45.68M	-$10.22M	-$9.50M	-$5.32M	$13.91M
EBITDA	-$2.12M	$45.82M	-$10.08M	-$9.35M	-$5.17M	$14.06M
Pretax Income	-$570.41K	$47.27M	-$8.36M	-$7.96M	-$4.04M	$14.85M
Income Tax	-$162.19K	$11.79M	-$1.99M	-$2.53M	-$589.43K	$2.39M
Net Income	-$408.22K	$35.48M	-$6.37M	-$5.43M	-$3.45M	$12.46M
Diluted EPS	-0.01	0.49	-0.09	—	-0.05	0.17
Diluted Shares	71.43M	71.75M	71.60M	—	71.65M	71.88M

SIGA Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$162.27M	$182.46M	$171.96M	$154.97M	$145.56M	$117.58M
Receivables	$7.19M	$6.49M	$2.49M	$3.26M	$4.50M	$7.17M
Inventory	$59.06M	$35.62M	$48.01M	$49.05M	$56.49M	$41.11M
Current Assets	$233.62M	$229.20M	$227.75M	$212.86M	$211.53M	$170.38M
Total Assets	$247.07M	$235.33M	$231.60M	$219.47M	$219.39M	$175.74M
Current Liabilities	$27.80M	$22.72M	$24.84M	$17.99M	$65.16M	$7.85M
Total Debt	$558.65K	$570.43K	$582.67K	$595.17K	$538.23K	$439.40K
Total Liabilities	$30.93M	$26.02M	$28.12M	$20.65M	$67.77M	$10.45M
Retained Earnings	-$23.25M	-$31.28M	-$37.64M	-$43.07M	-$90.44M	-$77.98M
Shareholders' Equity	$216.13M	$209.31M	$203.48M	$198.82M	$151.62M	$165.29M
Working Capital	$205.82M	$206.49M	$202.90M	$194.86M	$146.37M	$162.53M

SIGA Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$7.06M	$63.08M	-$9.81M	-$16.86M	-$8.66M	$15.17M
Capital Expenditure	-$24.89K	-$1.00	-$289.58K	-$40.54K	—	—
Free Cash Flow	$7.04M	$63.08M	-$10.10M	-$16.90M	-$8.66M	$15.17M
Depreciation & Amortisation	$135.31K	$138.99K	$141.79K	$146.52K	$149.95K	$152.22K
Stock-Based Compensation	$902.28K	$1.23M	$774.10K	$772.54K	$752.97K	$1.21M
Investing Cash Flow	-$24.89K	-$1.00	-$289.58K	-$40.54K	$0.00	$0.00
Financing Cash Flow	-$166.19K	-$42.89M	-$403.48K	-$87.82K	-$740.38K	-$43.15M
Dividends Paid	$0.00	-$42.87M	-$162.02K	-$87.82K	-$159.38K	-$43.15M
Net Change in Cash	$6.87M	$20.19M	-$10.51M	-$16.99M	-$9.40M	-$27.98M

Market Snapshot

About

SIGA Technologies is a commercial-stage pharmaceutical company focused on health security markets, particularly medical countermeasures for biodefense. The company developed and markets TPOXX, an antiviral treatment for smallpox and other orthopoxviruses. SIGA works with government agencies and international organizations on preparedness programs.